Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul, Korea.
CK Biotech, Inc., Seodaemun-Gu, Korea.
Adv Wound Care (New Rochelle). 2022 Feb;11(2):70-86. doi: 10.1089/wound.2020.1284. Epub 2021 Apr 20.
In adult mammals, spontaneous repair of a cutaneous wound occurs slowly and leaves a scar with skin adnexa deficiencies. To accelerate cutaneous wound-healing rates and avoid scar formation, current studies have focused on regenerative therapies. Emerging therapeutics for regenerative wound healing often focus on the use of growth factors and stem cells. However, these therapeutic approaches have limited routine clinical use due to high costs and technical requirements. Understanding the molecular mechanisms involved in the signaling pathways for cutaneous wound healing and neogenic synthesis of the skin components is important for identification of novel targets for the development of regenerative wound-healing agents. The Wnt/β-catenin pathway is a well-known key player for enhancement of the overall healing process involving tissue regeneration via crosstalk with other signaling pathways. Strategies that activate the Wnt/β-catenin pathway via modulation of the pathway-controlling regulatory factors could provide effective therapeutic approaches for regenerative wound healing.
在成年哺乳动物中,皮肤创伤的自发修复过程较为缓慢,且会留下伴有皮肤附属物缺失的疤痕。为了提高皮肤创伤的愈合速度并避免疤痕形成,目前的研究主要集中在再生疗法上。新兴的再生创伤愈合疗法通常侧重于生长因子和干细胞的应用。然而,由于成本高和技术要求高,这些治疗方法的常规临床应用受到限制。了解参与皮肤创伤愈合信号通路和皮肤成分新生合成的分子机制,对于确定用于开发再生创伤愈合剂的新型靶标至关重要。Wnt/β-连环蛋白途径是一个众所周知的关键调控因子,通过与其他信号通路的相互作用,增强整体愈合过程中的组织再生。通过调节途径调控因子来激活 Wnt/β-连环蛋白途径的策略,可能为再生创伤愈合提供有效的治疗方法。